首页> 美国卫生研究院文献>other >Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
【2h】

Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery

机译:用于口服/口腔给药的纳米基质药物递送系统的药代动力学方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oral route maintains its predominance among the ones used for drug delivery, especially when medicines are self-administered. If the dosage form is solid, therapy gains in dose precision and drug stability. Yet, some active pharmaceutical substances do not present the required solubility, permeability, or release profile for incorporation into traditional matrices. The combination of nanostructured drugs (nanoparticle [NP]) with these matrices is a new and little-explored alternative, which could bring several benefits. Therefore, this review focused on combined delivery systems based on nanostructures to administer drugs by the oral cavity, intended for buccal, sublingual, gastric, or intestinal absorption. We analyzed published NP-in-matrix systems and compared main formulation characteristics, pharmacokinetics, release profiles, and physicochemical stability improvements. The reported formulations are mainly semisolid or solid polymers, with polymeric or lipid NPs and one active pharmaceutical ingredient. Regarding drug specifics, most of them are poorly permeable or greatly metabolized. The few studies with pharmacokinetics showed increased drug bioavailability and, sometimes, a controlled release rate. From our knowledge, the gathered data make up the first focused review of these trendy systems, which we believe will help to gain scientific deepness and future advancements in the field.
机译:口服途径在用于药物输送的途径中保持其优势,尤其是在自行给药的情况下。如果剂型是固体,则治疗可提高剂量精确度和药物稳定性。然而,一些活性药物物质不具有掺入传统基质中所需的溶解度,渗透性或释放特性。纳米结构药物(纳米颗粒[NP])与这些基质的结合是一种新的且鲜为人知的替代方法,它可以带来许多好处。因此,本综述着重于基于纳米结构的联合递送系统,以通过口腔给药,用于口腔,舌下,胃或肠道吸收。我们分析了已发布的NP-in-matrix系统,并比较了主要制剂特性,药代动力学,释放曲线和理化稳定性改进。报告的制剂主要是半固体或固体聚合物,具有聚合物或脂质NP和一种活性药物成分。关于药物特性,大多数药物渗透性差或被大量代谢。几项有关药代动力学的研究表明,药物的生物利用度提高,有时控制释放速率。根据我们的知识,所收集的数据构成了对这些流行系统的首次重点审查,我们相信这将有助于获得该领域的科学深度和未来发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号